Marinus Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Incyte USD 2.41B 720.83M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
UCB EUR 1.57B 1.14B 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Marinus Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.